NCT05362851

Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee

a Multicenter, Double-blind, Randomized, Active Drug Control, Parallel Design Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of YYC301 in Patients With Osteoarthritis of the Knee Joint

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 692 (estimated)
• Sponsor: Yooyoung Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

A Multi-center, Double-blinded, Randomized, Active-controlled, Parallel Design, phase 3 Clinical Trial to Evaluate the Efficacy and Safety of YYC301 in Patients with Osteoarthritis of the Knee Joint

Conditions

• Osteoarthritis, Knee

Interventions

Type	Name	Description
DRUG	YYC301-1 & YYC301-2 & YYC301-3	YYC301-1: Subjects take the investigational products once a day YYC301-2: Subjects take the investigational products once a day YYC301-3: Subjects take the investigational products once a day
DRUG	YYC301 placebo & Celecoxib 200mg	comparator medication

Timeline

• Start date: 2021-11-11
• Primary completion: 2023-01-31
• Completion: 2023-03-31
• First posted: 2022-05-05
• Last updated: 2022-05-05

Locations

1 site across 1 country: South Korea